IRON

$0.00

(

+0.00%

)
Quote details

stock

Disc Medicine Inc.

NASDAQ | IRON

89.94

USD

+$0.00

(

+0.00%

)

At Close (As of Oct 17, 2025)

$3.13B

Market Cap

-

P/E Ratio

-4.46

EPS

$95.95

52 Week High

$30.82

52 Week Low

HEALTHCARE

Sector

IRON Chart

Recent Chart
Price Action

IRON Technicals

Tags:

IRON Earnings

Yearly Income Statement (As of Dec 31, 2024)

Field Value (USD)
Gross Profit -$156K
Total Revenue $0
Cost Of Revenue $156K
Costof Goods And Services Sold $156K
Operating Income -$130M
Selling General And Administrative $33M
Research And Development $97M
Operating Expenses $130M
Investment Income Net -
Net Interest Income $21M
Interest Income $21M
Interest Expense $572K
Non Interest Income -
Other Non Operating Income -
Depreciation -
Depreciation And Amortization $156K
Income Before Tax -$109M
Income Tax Expense $355K
Interest And Debt Expense -
Net Income From Continuing Operations -$109M
Comprehensive Income Net Of Tax -
Ebit -$108M
Ebitda -$108M
Net Income -$109M

Revenue & Profitability

Earnings Performance

IRON Financials

yearly Balance Sheet (As of Dec 31, 2024)

Field Value (USD)
Total Assets $497M
Total Current Assets $494M
Cash And Cash Equivalents At Carrying Value $192M
Cash And Short Term Investments $192M
Inventory -
Current Net Receivables -
Total Non Current Assets $3.2M
Property Plant Equipment -
Accumulated Depreciation Amortization Ppe -
Intangible Assets -
Intangible Assets Excluding Goodwill -
Goodwill -
Investments -
Long Term Investments -
Short Term Investments $297M
Other Current Assets $3.7M
Other Non Current Assets -
Total Liabilities $53M
Total Current Liabilities $23M
Current Accounts Payable $7.9M
Deferred Revenue -
Current Debt -
Short Term Debt $260K
Total Non Current Liabilities $30M
Capital Lease Obligations $1.7M
Long Term Debt $28M
Current Long Term Debt -
Long Term Debt Noncurrent -
Short Long Term Debt Total $30M
Other Current Liabilities $15M
Other Non Current Liabilities -
Total Shareholder Equity $444M
Treasury Stock -
Retained Earnings -$298M
Common Stock $3K
Common Stock Shares Outstanding $28M

yearly Cash Flow (As of Dec 31, 2024)

Field Value (USD)
Operating Cashflow -$94M
Payments For Operating Activities -
Proceeds From Operating Activities -
Change In Operating Liabilities -
Change In Operating Assets -
Depreciation Depletion And Amortization $156K
Capital Expenditures $505K
Change In Receivables -
Change In Inventory -
Profit Loss -
Cashflow From Investment -$292M
Cashflow From Financing $218M
Proceeds From Repayments Of Short Term Debt -
Payments For Repurchase Of Common Stock -
Payments For Repurchase Of Equity -
Payments For Repurchase Of Preferred Stock -
Dividend Payout -
Dividend Payout Common Stock -
Dividend Payout Preferred Stock -
Proceeds From Issuance Of Common Stock -
Proceeds From Issuance Of Long Term Debt And Capital Securities Net -
Proceeds From Issuance Of Preferred Stock -
Proceeds From Repurchase Of Equity -
Proceeds From Sale Of Treasury Stock -
Change In Cash And Cash Equivalents -
Change In Exchange Rate -
Net Income -$109M

yearly Income Statement (As of Dec 31, 2024)

Field Value (USD)
Gross Profit -$156K
Total Revenue $0
Cost Of Revenue $156K
Costof Goods And Services Sold $156K
Operating Income -$130M
Selling General And Administrative $33M
Research And Development $97M
Operating Expenses $130M
Investment Income Net -
Net Interest Income $21M
Interest Income $21M
Interest Expense $572K
Non Interest Income -
Other Non Operating Income -
Depreciation -
Depreciation And Amortization $156K
Income Before Tax -$109M
Income Tax Expense $355K
Interest And Debt Expense -
Net Income From Continuing Operations -$109M
Comprehensive Income Net Of Tax -
Ebit -$108M
Ebitda -$108M
Net Income -$109M

IRON News

IRON Profile

Disc Medicine Inc. Profile

Sector: HEALTHCARE

Industry: BIOTECHNOLOGY

Disc Medicine Inc. (IRON) is a clinical-stage biotechnology company headquartered in Watertown, Massachusetts, dedicated to the advancement of innovative therapies for patients with serious hematologic diseases. The company boasts a comprehensive pipeline designed to target significant unmet medical needs in hematology, utilizing state-of-the-art drug development methodologies and thorough scientific research. Disc Medicine is strategically positioned to reshape the treatment paradigm for hematologic conditions, reflecting its ongoing commitment to enhancing patient outcomes through groundbreaking scientific advancements.

VHAI
-25.00%
$0.00
RANI
+248.26%
$1.64
BYND
+24.15%
$0.64
YYAI
+0.83%
$0.12
YDKG
-40.50%
$0.05
CGBS
-39.47%
$0.03
BITF
-5.11%
$5.01
NVDA
+0.77%
$183.22
INTC
+0.46%
$37.01
RGTI
-3.31%
$46.38
GDXD
+20.23%
$0.72
F
+1.53%
$11.92
PLUG
-2.29%
$3.40
ARTV
+116.96%
$6.01
BURU
+0.85%
$0.34
TSLA
+2.46%
$439.31
DNN
-5.50%
$2.92
BBD
+1.22%
$3.30
IONZ
+7.55%
$3.70
HBAN
+0.84%
$15.50
NIO
-1.17%
$6.75
CAN
-4.19%
$1.60
NVTS
-6.20%
$14.66
HIMS
-15.84%
$49.78
RXRX
-7.86%
$5.86
TLRY
+1.29%
$1.56
AXDX
-61.36%
$0.03
BTG
-6.56%
$5.55
HPE
+2.04%
$22.96
LAES
+4.87%
$6.67
RGTZ
+6.58%
$11.97
T
+0.53%
$26.34
ETHD
+2.25%
$4.09
ELBM
+35.36%
$2.22
BLMZ
-3.85%
$0.18
ACHR
-5.30%
$11.24
AMD
-0.63%
$233.08
WTO
-47.99%
$0.07
CIFR
+0.21%
$18.76
KVUE
+8.36%
$15.29
GNPX
-23.68%
$0.36
LNKS
+30.35%
$0.73
RIG
+0.92%
$3.26
GPUS
-11.96%
$0.32
MARA
-3.42%
$19.57
AAPL
+1.95%
$252.29
BAC
+1.66%
$51.28
SOFI
-0.22%
$26.54
JOBY
-2.55%
$15.66
SOUN
-8.38%
$19.02
RF
+0.98%
$23.58
AMZN
-0.66%
$213.04
QBTS
-5.26%
$38.33
PLTR
+0.01%
$178.15
EPWK
-18.45%
$0.07
ONDS
-7.19%
$7.61
GRAB
-1.22%
$5.64
QUBT
-2.18%
$18.32
ADAP
+2.51%
$0.20
PFE
+1.15%
$24.51
RMBL
+60.50%
$3.21
SLB
-0.88%
$32.63
BMNR
-2.40%
$49.85
ABEV
+0.89%
$2.25
IREN
-1.79%
$60.72
ASST
-7.28%
$0.83
ADD
-25.47%
$0.05
SNAP
-1.41%
$7.65
ORCL
-6.92%
$291.31
CRML
+7.41%
$20.86
DFLI
+2.25%
$1.36
BTBT
-1.08%
$3.65
VIVK
-29.17%
$0.20
SRM
+53.27%
$10.30
AAL
-0.25%
$11.86
NUAI
+44.44%
$4.55
NEHC
+44.44%
$4.55
IONQ
-4.04%
$62.94
WULF
+0.50%
$13.93
NAK
-8.48%
$2.04
NOK
+1.05%
$5.74
ATAI
+17.70%
$6.45
RR
-4.05%
$5.44
SMR
-7.11%
$44.25
CLSK
-2.32%
$19.52
GWH
+16.04%
$5.28
APLD
-6.55%
$34.24
CRWV
-3.43%
$136.87
UUUU
-2.90%
$21.06
QS
-0.64%
$15.36
GOOGL
+0.73%
$253.30
CUTR
-10.19%
$0.09
PET
-59.91%
$0.04
VALE
-0.09%
$11.10
WLGS
-5.57%
$0.04
FNB
+3.00%
$15.09
BULL
-6.29%
$11.01
AG
-8.48%
$14.03
FEMY
-5.67%
$0.70
WOK
-31.91%
$0.03
VHAI
-25.00%
$0.00
RANI
+248.26%
$1.64
BYND
+24.15%
$0.64
YYAI
+0.83%
$0.12
YDKG
-40.50%
$0.05
CGBS
-39.47%
$0.03
BITF
-5.11%
$5.01
NVDA
+0.77%
$183.22
INTC
+0.46%
$37.01
RGTI
-3.31%
$46.38
GDXD
+20.23%
$0.72
F
+1.53%
$11.92
PLUG
-2.29%
$3.40
ARTV
+116.96%
$6.01
BURU
+0.85%
$0.34
TSLA
+2.46%
$439.31
DNN
-5.50%
$2.92
BBD
+1.22%
$3.30
IONZ
+7.55%
$3.70
HBAN
+0.84%
$15.50
NIO
-1.17%
$6.75
CAN
-4.19%
$1.60
NVTS
-6.20%
$14.66
HIMS
-15.84%
$49.78
RXRX
-7.86%
$5.86
TLRY
+1.29%
$1.56
AXDX
-61.36%
$0.03
BTG
-6.56%
$5.55
HPE
+2.04%
$22.96
LAES
+4.87%
$6.67
RGTZ
+6.58%
$11.97
T
+0.53%
$26.34
ETHD
+2.25%
$4.09
ELBM
+35.36%
$2.22
BLMZ
-3.85%
$0.18
ACHR
-5.30%
$11.24
AMD
-0.63%
$233.08
WTO
-47.99%
$0.07
CIFR
+0.21%
$18.76
KVUE
+8.36%
$15.29
GNPX
-23.68%
$0.36
LNKS
+30.35%
$0.73
RIG
+0.92%
$3.26
GPUS
-11.96%
$0.32
MARA
-3.42%
$19.57
AAPL
+1.95%
$252.29
BAC
+1.66%
$51.28
SOFI
-0.22%
$26.54
JOBY
-2.55%
$15.66
SOUN
-8.38%
$19.02
RF
+0.98%
$23.58
AMZN
-0.66%
$213.04
QBTS
-5.26%
$38.33
PLTR
+0.01%
$178.15
EPWK
-18.45%
$0.07
ONDS
-7.19%
$7.61
GRAB
-1.22%
$5.64
QUBT
-2.18%
$18.32
ADAP
+2.51%
$0.20
PFE
+1.15%
$24.51
RMBL
+60.50%
$3.21
SLB
-0.88%
$32.63
BMNR
-2.40%
$49.85
ABEV
+0.89%
$2.25
IREN
-1.79%
$60.72
ASST
-7.28%
$0.83
ADD
-25.47%
$0.05
SNAP
-1.41%
$7.65
ORCL
-6.92%
$291.31
CRML
+7.41%
$20.86
DFLI
+2.25%
$1.36
BTBT
-1.08%
$3.65
VIVK
-29.17%
$0.20
SRM
+53.27%
$10.30
AAL
-0.25%
$11.86
NUAI
+44.44%
$4.55
NEHC
+44.44%
$4.55
IONQ
-4.04%
$62.94
WULF
+0.50%
$13.93
NAK
-8.48%
$2.04
NOK
+1.05%
$5.74
ATAI
+17.70%
$6.45
RR
-4.05%
$5.44
SMR
-7.11%
$44.25
CLSK
-2.32%
$19.52
GWH
+16.04%
$5.28
APLD
-6.55%
$34.24
CRWV
-3.43%
$136.87
UUUU
-2.90%
$21.06
QS
-0.64%
$15.36
GOOGL
+0.73%
$253.30
CUTR
-10.19%
$0.09
PET
-59.91%
$0.04
VALE
-0.09%
$11.10
WLGS
-5.57%
$0.04
FNB
+3.00%
$15.09
BULL
-6.29%
$11.01
AG
-8.48%
$14.03
FEMY
-5.67%
$0.70
WOK
-31.91%
$0.03

Charts powered by TradingView


Market data may be delayed by 15 minutes or more and is provided by financial exchanges or third-party providers. AfterPullback does not verify or guarantee its accuracy and assumes no responsibility to do so. This website is not operated by a licensed attorney, accountant, or financial advisor. Nothing on this site constitutes financial advice or replaces consultation with a qualified professional who understands your specific circumstances. Always consult a licensed financial advisor before making investment decisions.